Dealsiuvo BioScience scoops up ophthalmology-focused clinical CRO Promedica InternationalAmpersand Capital Partners is backing the combined business.ByIris Dorbian19 January 2024•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs